CLLS
CellectisANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
CLLS vs peer average
95/100
CLLS vs. peer average (A vs. D)
Grade spread
A 1 · B 1 · C 1 · D 1 · F 5
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
NKTX is the first available peer comparator.
Nkarta is the closest packet peer for development-stage cell-therapy framing, but differences in targets and programs mean it is more useful for financing and catalyst-volatility context than for direct clinical read-through.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CLLS
Cellectis
NKTX
Nkarta
Grade
A
D
Momentum
95
57
Value
41
41
Sentiment
70
43
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs NKTX
CLLS / NKTX
Grade Position
Above peers
CLLS vs. peer average (A vs. D)
95/100
Momentum
95
CLLSValue
41
CLLSSentiment
70
CLLSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CLLS
NKTX is the first peer returned for this comparison set.